Over the past decade, the cardiovascular care of patients with cancer has evolved as a subspecialty driven by novel therapies that can cure or control cancer, particularly because many patients are now living long enough to experience the potential cardiotoxic effects of these new treatments. The purpose of this conference is to provide a case-based curriculum that addresses important clinical topics relevant to the management of the cardiovascular health of patients with cancer. Experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on the evaluation and management of heart disease in cancer patients covering early diagnosis, treatment and long-term surveillance. All presentations will include devoted time to permit interaction between audience members and presenters.
By the end of this course, participants will be able to:
- Describe the cardiotoxic regimens used in cancer treatment including novel targeted therapies
- Explain the principles of surveillance, primary prevention and treatment of underlying cardiovascular diseases during cancer therapies
- State specific examples of cardiovascular challenges during cancer therapy
- Summarize existing recommendations regarding cardiac monitoring during and post cancer therapy and develop an understanding of the newer methods of cardiotoxicity monitoring.
This course is intended for cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have a special interest in this area.
MSK is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.